| For: | Mpilla GB, Philip PA, El-Rayes B, Azmi AS. Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations. World J Gastroenterol 2020; 26(28): 4036-4054 [PMID: 32821069 DOI: 10.3748/wjg.v26.i28.4036] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i28/4036.htm |
| Number | Citing Articles |
| 1 |
X. Liu, B. Chen, J. Chen, Z. Su, S. Sun. The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States. Journal of Endocrinological Investigation 2022; 46(7) doi: 10.1007/s40618-022-01985-2
|
| 2 |
Srujana V. Yellapragada, Steven D. Forsythe, James P. Madigan, Samira M. Sadowski. The Role of the Tumor Microenvironment in Gastroenteropancreatic Neuroendocrine Tumors. International Journal of Molecular Sciences 2025; 26(12) doi: 10.3390/ijms26125635
|
| 3 |
Yuan Zhou, Maoen Pan, Ronggui Lin, Heguang Huang. Advances in hydrogel materials applied to pancreatic-related diseases. Journal of Pancreatology 2024; 7(3) doi: 10.1097/JP9.0000000000000158
|
| 4 |
Bokyung Ahn, Joo Young Kim, Seung-Mo Hong. Combined Infiltrative Macroscopic Growth Pattern and Infiltrative Microscopic Tumor Border Status Is a Novel Surrogate Marker of Poor Prognosis in Patients With Pancreatic Neuroendocrine Tumor. Archives of Pathology & Laboratory Medicine 2023; 147(1) doi: 10.5858/arpa.2021-0475-OA
|
| 5 |
Jiehui Tan, Yijie Hao, Caihong Zhou, Jinmei Tan, Wenhao Chen, Jiawei Liu, Yanjie Li, Jianliang Xu, Nan Lin. Genetic evidence for the causal impact of immune cells on pancreatic neuroendocrine tumors and the mediating effects of cathepsins. Pancreatology 2025; 25(6) doi: 10.1016/j.pan.2025.08.002
|
| 6 |
Kaitlyn B. Conley, Kathleen C. Brown, Javan C. Christian, Kushal J. Modi, Christopher R. Bender, Sarah E. McGuffey, Sadia Akter, Sarah L. Miles, Todd W. Gress, Rebecca S. Wolfer, Brian D. Antoniano, Gregory H. Cummings, Krista L. Denning, Monica A. Valentovic, Piyali Dasgupta. . Advances in Cancer Research 2026; doi: 10.1016/bs.acr.2026.07.001
|
| 7 |
Zena Saleh, Rachel J. Nation, Matthew C. Moccia, Ami Kalola, Yazid Ghanem, Hansa Joshi, Upasana Joneja, Yahui Li, Francis Spitz, Tao Gao, Young Ki Hong. DNA methyltransferase 1 correlates with immune modulation in pancreatic neuroendocrine tumors. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-25384-8
|
| 8 |
Rong Kong, Shunzu Lu, Yugui Huang, Siyu Tan, Chunxia Zhu, Guowei Chen, Mingrui Yang, Ying Liu, Qixin Wu, Peng Peng. A CT-based interpretable machine learning model for preoperative prediction of pancreatic neuroendocrine tumor aggressiveness. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1665601
|
| 9 |
Jessica Wedig, Shrina Jasani, Debasmita Mukherjee, Hannah Lathrop, Priya Matreja, Timothy Pfau, Liliana D’Alesio, Abigail Guenther, Lexie Fenn, Morgan Kaiser, Molly A. Torok, Jake McGue, Gina M. Sizemore, Anne M. Noonan, Mary E. Dillhoff, Bradley W. Blaser, Timothy L. Frankel, Stacey Culp, Phil A. Hart, Zobeida Cruz-Monserrate, Thomas A. Mace. CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survival. Cancer Immunology, Immunotherapy 2024; 73(6) doi: 10.1007/s00262-024-03678-6
|
| 10 |
Angela Ragone, Alessia Salzillo, Annamaria Spina, Silvio Naviglio, Luigi Sapio. Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.837503
|
| 11 |
Zhen Yang, Guangjun Shi. Comparative outcomes of pancreatic neuroendocrine neoplasms: A population-based analysis of the SEER database. European Journal of Surgical Oncology 2022; 48(10) doi: 10.1016/j.ejso.2022.05.016
|
| 12 |
莹 冯. Comparison of Imaging Features of Hypovascular and Hypervascular Pancreatic Neuroendocrine Neoplasm. Advances in Clinical Medicine 2024; 14(05) doi: 10.12677/acm.2024.1451613
|
| 13 |
Karolina Skubisz, Krzysztof Dąbkowski, Emilia Samborowska, Teresa Starzyńska, Anna Deskur, Filip Ambrozkiewicz, Jakub Karczmarski, Mariusz Radkiewicz, Katarzyna Kusnierz, Beata Kos-Kudła, Tadeusz Sulikowski, Patrycja Cybula, Agnieszka Paziewska. Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study. Cancers 2023; 15(12) doi: 10.3390/cancers15123242
|
| 14 |
Weixuan Liu, Bairui Zhang, Tao Liu, Juntao Jiang, Yong Liu. Artificial Intelligence in Pancreatic Image Analysis: A Review. Sensors 2024; 24(14) doi: 10.3390/s24144749
|
| 15 |
Mujie Ye, Feiyu Lu, Danyang Gu, Bingyan Xue, Lin Xu, Chuanhua Hu, Jinhao Chen, Ping Yu, Hongxia Zheng, Yue Gao, Jianhua Wang, Qiyun Tang. Hypoxia exosome derived CEACAM5 promotes tumor‐associated macrophages M2 polarization to accelerate pancreatic neuroendocrine tumors metastasis via MMP9. The FASEB Journal 2024; 38(13) doi: 10.1096/fj.202302489RRR
|
| 16 |
Zhen Yang, Jie Liang, Kaiming Leng, Guangjun Shi. Survival Benefit of Surgical Resection for Pancreatic Neuroendocrine Tumors With Oligometastatic Liver Metastasis: A Retrospective and Propensity Score-Matching Analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.903560
|
| 17 |
Xinchao Ban, Shengwei Mo, Zhaohui Lu, Congwei Jia, Huilin Shao, Xiaoyan Chang, Xinxin Mao, Yue Zhang, Junyi Pang, Yuhan Zhang, Shuangni Yu, Jie Chen. Expression and methylation status of MMR and MGMT in well-differentiated pancreatic neuroendocrine tumors and potential clinical applications. Endocrine 2022; 77(3) doi: 10.1007/s12020-022-03102-y
|
| 18 |
Li Quan, Yongkang Liu, Wenjing Cui, Xinru Wang, Weixiao Zhang, Zhongqiu Wang, Chuangen Guo, Chao Lu, Feixiang Hu, Xiao Chen. The associations between serum high-density lipoprotein cholesterol levels and malignant behavior in pancreatic neuroendocrine neoplasms. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01669-z
|
| 19 |
Ramazan GÜNDOĞDU, Serkan ERKAN, Hakan YABANOĞLU, M. Eda ERTÖRER, Esra Zeynep COŞKUNOĞLU, Fatma ÖZARSLAN. Pankreas Nöroendokrin Tümörlerinin Cerrahi Tedavisinde 11 Yıllık Tek Merkez Deneyimi. Harran Üniversitesi Tıp Fakültesi Dergisi 2022; 19(2) doi: 10.35440/hutfd.1126786
|
| 20 |
Jianbo Li, Long Huang, Chengyu Liao, Guozhong Liu, Yifeng Tian, Shi Chen. Two machine learning-based nomogram to predict risk and prognostic factors for liver metastasis from pancreatic neuroendocrine tumors: a multicenter study. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10893-4
|
| 21 |
Fei Wang, Jihyun Ma, Nan Zhao, Chi Lin, Haixing Jiang. Racial Disparities in Clinical Features and Survival Outcomes among Patients with Pancreatic Neuroendocrine Tumor: A Contemporary SEER Database Analysis. Oncologie 2022; 24(4) doi: 10.32604/oncologie.2022.025447
|
| 22 |
Anna Vera D Verschuur, Lin Chen, Els J Nieveen van Dijkum, Claudio Luchini, Thorvardur R Halfdanarson, Seung-Mo Hong, Aatur D Singhi, Lodewijk A A Brosens, Christopher M Heaphy. Management of patients with small pancreatic neuroendocrine tumors from a biomarker and surgical perspective. Endocrine-Related Cancer 2025; 32(5) doi: 10.1530/ERC-24-0305
|
| 23 |
Myrto Potiri, Charikleia Moschou, Zoi Erpapazoglou, Georgia Rouni, Anastasia Kotsoni, Margarita Andreadou, Anastasios Klavdianos, Melina Dragolia, Vasileios Ntafis, Joerg Schrader, Jonas Juan-Mateu, Skarlatos G. Dedos, Martina Samiotaki, Vassiliki Kostourou, Malgorzata E. Rogalska, Panagiota Kafasla. An SRRM3-regulated neural alternative splicing program is subverted to promote tumor progression in pancreatic neuroendocrine cells. Cell Reports 2025; 44(8) doi: 10.1016/j.celrep.2025.116022
|
| 24 |
Zhen Yang, Dongsheng Zhang, Guangjun Shi. Reappraisal of a 2-cm Cutoff Size for the Management of Nonfunctional Pancreatic Neuroendocrine Tumors: A Population-Based Study. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.928341
|
| 25 |
Bor-Shiuan Shyr, Bor-Uei Shyr, Shih-Chin Chen, Yi-Ming Shyr, Shin-E Wang. Impact of tumor grade on pancreatic neuroendocrine tumors. Asian Journal of Surgery 2022; 45(12) doi: 10.1016/j.asjsur.2022.01.094
|
| 26 |
Intelligent Systems Design and Applications. Lecture Notes in Networks and Systems 2024; 1046 doi: 10.1007/978-3-031-64813-7_3
|
| 27 |
Mengfei Fu, Li Yu, Liu Yang, Yang Chen, Xiao Chen, Qinyu Hu, Hui Sun. Gender differences in pancreatic neuroendocrine neoplasms: A retrospective study based on the population of Hubei Province, China. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.885895
|
| 28 |
Ruofei Li, Yingying Li, Su Wu, Zhifen Zhou, Xinyu Hou, Ping Yang, Jun Zhu, Ying Xia, Wenchao Wu, Ran Feng, Qiuyuan Gao, Kunling Huang, Yi Liu, Jianfei Zheng, Xiaoqin Zhong, Hui Huang, Cheng Chang, Wenbin Ma, Zhou Songyang, Feng Liu. Proximal proteomics reveals a landscape of human nuclear condensates. Nature Cell Biology 2025; 27(12) doi: 10.1038/s41556-025-01809-4
|
| 29 |
Nian Guo, Zhen Liang, Li Jiao Xiong. Clinicopathological characteristics, survival outcomes and prognostic factors in the cT1N0M0 pancreatic neuroendocrine tumors: A SEER-based study. Medicine 2022; 101(41) doi: 10.1097/MD.0000000000031019
|
| 30 |
Feiyu Lu, Mujie Ye, Chunhua Hu, Jinhao Chen, Lijun Yan, Danyang Gu, Lin Xu, Ye Tian, Jianan Bai, Qiyun Tang. FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β‐catenin pathway. Cancer Science 2023; 114(9) doi: 10.1111/cas.15883
|
| 31 |
Wei Li, Chao Xu, Zhaoxiang Ye. Prediction of Pancreatic Neuroendocrine Tumor Grading Risk Based on Quantitative Radiomic Analysis of MR. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.758062
|
| 32 |
Khyati Bidani, Angela G. Marinovic, Vishali Moond, Prateek Harne, Arkady Broder, Nirav Thosani. Treatment of Pancreatic Neuroendocrine Tumors: Beyond Traditional Surgery and Targeted Therapy. Journal of Clinical Medicine 2025; 14(10) doi: 10.3390/jcm14103389
|
| 33 |
Jacek Kabut, Jakub Sokołowski, Wiktoria Żelazna, Mateusz Stępień, Marta Strauchman, Natalia Jaworska, Anita Gorzelak-Magiera, Jakub Wnuk, Iwona Gisterek-Grocholska. Heat Shock Proteins in Gastrointestinal and Lung Neuroendocrine Neoplasm: Diagnostic and Therapeutic Perspectives. Cells 2025; 14(19) doi: 10.3390/cells14191501
|
| 34 |
Ana Stolnicu, Peter Eckhardt-Bellmann, Angelika M. R. Kestler, Hans A. Kestler. Identification of ordinal relations and alternative suborders within high-dimensional molecular data. Frontiers in Bioinformatics 2025; 5 doi: 10.3389/fbinf.2025.1665892
|
| 35 |
Faten Cherchir, Ines Naceur, Ahmed Anas Haouari, Tayssir Ben Achour, Hajer Ben Mansour, Khadija Bellil, Fatma Said, Mohamed Habib Houman. Unilateral pseudouveitis revealing a pancreatic neuroendocrine carcinoma: A case report. Clinical Case Reports 2022; 10(3) doi: 10.1002/ccr3.5563
|
| 36 |
Nutu Vlad, Florina Delia Andriesi-Rusu, Andrei Chicos, Ana Maria Trofin, Ramona Cadar, Mihai Lucian Zabara, Delia Ciobanu, Mircea Costache, Corina Lupascu-Ursulescu, Alin Mihai Vasilescu, Costel Bradea, Mihaela Blaj, Oana Maria Lovin, Adi Ionut Ciumanghel, Felicia Crumpei, Cristian Dumitru Lupascu. Predicting Factor for Occurrence of Postoperative Pancreatic Fistula in Patients with Pancreatic Neuroendocrine Tumors. Diagnostics 2025; 15(3) doi: 10.3390/diagnostics15030268
|
| 37 |
Hai-Feng Hu, Yu-Heng Hu, Xiao-Wu Xu, Zeng Ye, Xin Lou, Wu-Hu Zhang, Xue-Min Chen, Yue Zhang, Xian-Jun Yu, He-Li Gao, Jun-Yan Xu, Shun-Rong Ji. Role of Somatostatin Receptor 2 in Nonfunctional Pancreatic Neuroendocrine Tumors. Pancreas 2022; 51(10) doi: 10.1097/MPA.0000000000002199
|
| 38 |
Luisa Montemayor Burrola, Hugo López, América Ulate, Edgar Martínez Rosales. Atypical presentation and diagnosis of a metastatic grade II pancreatic neuroendocrine tumor in a 52‑year‑old female patient: A case report. Medicine International 2025; 5(6) doi: 10.3892/mi.2025.271
|
| 39 |
Ibrahim Azar, Husain Yar Khan, Sahar F. Bannoura, Nishant Gandhi, Md Hafiz Uddin, Misako Nagasaka, Jun Gong, Bassel Nazha, Khalil Choucair, Nikhil Vojjala, Moh'd M. Khushman, Heloisa P. Soares, Wafik S. El-Deiry, Philip Agop Philip, Bassel El-Rayes, Herbert Chen, Emil Lou, Irfana Muqbil, Alex Patrick Farrell, Jeffrey Swensen, Matthew James Oberley, Chadi Nabhan, Sanjay Goel, Anthony F. Shields, Ramzi M. Mohammad, Boris C. Pasche, Asfar S. Azmi. Molecular Characterization and Clinical Outcomes of Pancreatic Neuroendocrine Neoplasms Harboring PAK4-NAMPT Alterations. JCO Oncology Advances 2025; (2) doi: 10.1200/OA-24-00032
|
| 40 |
Mengfei Fu, Li Yu, Liu Yang, Yang Chen, Xiao Chen, Qinyu Hu, Hui Sun. Predictive value of the preoperative prognostic nutritional index for postoperative progression in patients with pancreatic neuroendocrine neoplasms. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.945833
|
| 41 |
J. E. Machado-Alba, M. E. Machado-Duque, A. Gaviria-Mendoza, I. N. Arsof-Saab, C. A. Castellanos-Moreno, L. Botero, L. Triana. Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors. Journal of Endocrinological Investigation 2022; 46(1) doi: 10.1007/s40618-022-01875-7
|
| 42 |
Yu Chen, Tatsuki Yamamoto, Yura Takahashi, Tomoka Moro, Tomoko Tajima, Yukiko Sakaguchi, Naoaki Sakata, Akihiko Yokoyama, Susumu Hijioka, Akane Sada, Yuko Tabata, Rieko Ohki. Metabolic intervention by low carbohydrate diet suppresses the onset and progression of neuroendocrine tumors. Cell Death & Disease 2023; 14(9) doi: 10.1038/s41419-023-06123-1
|
| 43 |
Agnes Bocian-Jastrzębska, Anna Malczewska-Herman, Violetta Rosiek, Beata Kos-Kudła. Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms. Cancers 2023; 15(13) doi: 10.3390/cancers15133517
|
| 44 |
Samuel Frey, Eric Mirallié, Maëlle Le Bras, Nicolas Regenet. What Are the Place and Modalities of Surgical Management for Pancreatic Neuroendocrine Neoplasms? A Narrative Review. Cancers 2021; 13(23) doi: 10.3390/cancers13235954
|
| 45 |
Silke D. Werle, Nensi Ikonomi, Ludwig Lausser, Annika M. T. U. Kestler, Felix M. Weidner, Julian D. Schwab, Julia Maier, Malte Buchholz, Thomas M. Gress, Angelika M. R. Kestler, Hans A. Kestler. A systems biology approach to define mechanisms, phenotypes, and drivers in PanNETs with a personalized perspective. npj Systems Biology and Applications 2023; 9(1) doi: 10.1038/s41540-023-00283-8
|
| 46 |
Yining Li, Shuaiyang Zhou, Qiao Qiao, Ke Ji, Qin Li, Zhenguo Qiao, Ping Zhang. Gender Differences in Prognosis of Pancreatic Neuroendocrine Tumors: A Retrospective Cohort Study Based on the SEER Database. Cancer Control 2026; 33 doi: 10.1177/10732748261417419
|
| 47 |
Shiwei Guo, Xiaohan Shi, Xiaoyi Yin, Suizhi Gao, Bo Li, Huan Wang, Yikai Li, Beilei Wang, Xiongfei Xu, Kailian Zheng, Bin Song, Wei Jing, Chengli Song, Gang Jin. Integrated genomics and transcriptomics reveal key events in pancreatic neuroendocrine neoplasm. BMC Biology 2026; 24(1) doi: 10.1186/s12915-026-02637-0
|
| 48 |
Saif Onbargi, Walid Faraj, Deborah Mukherji. Robotic subtotal pancreatectomy for multifocal neuroendocrine tumour of the pancreas. BMJ Case Reports 2026; 19(6) doi: 10.1136/bcr-2025-270818
|
| 49 |
Matthew C. Moccia, Rachel Nation, T. Hess, Gena V. Topper, Ami Kalola, Michael Wang, Hannah Sofield, Zena Saleh, Xiaofeng Zhao, Yahui Li, Francis Spitz, Tao Gao, Young Ki Hong. Lighting up PNETs: Creating Murine Models with a Novel Bioluminescent Cell Line. Annals of Surgical Oncology 2026; 33(5) doi: 10.1245/s10434-026-19089-z
|